🔎 Trials Near Me

Home › Hodgkin Lymphoma › Tennessee

Hodgkin Lymphoma clinical trials in Tennessee

8 studies for Hodgkin Lymphoma are looking for participants at sites in Tennessee.

Cities in Tennessee

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

  • St. Jude Children's Research Hospital, Memphis
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06421987

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

  • St. Jude Children's Research Hospital, Memphis
Recruiting
All ages · All sexes · Updated Aug 21, 2026 · NCT07514819

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Tennessee Oncology, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT06150664

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • St. Jude Childrens Research Hospital, Memphis
  • Vanderbilt University, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Familial Investigations of Childhood Cancer Predisposition

  • St. Jude Children's Research Hospital, Memphis
RecruitingObservational study
All ages · All sexes · Updated Jun 17, 2026 · NCT03050268

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

  • St. Jude Children's Research Hospital, Memphis
Recruiting
Ages 10 to 25 · All sexes · Updated Jun 10, 2026 · NCT07222345

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

  • St. Jude Children's Research Hospital, Memphis
RecruitingObservational study
Ages 8 and older · All sexes · Updated May 20, 2026 · NCT06098430

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.